2026 Scientific Sessions

Pharmacotherapy Beyond the Cath Lab

This session explores the expanding role of pharmacologic therapies in cardiovascular care beyond the procedure room. Topics include emerging treatments for lipoprotein(a), aggressive lipid lowering, inflammation modulation, and cardiometabolic agents like SGLT2 inhibitors and GLP-1 receptor agonists. Faculty will also discuss the evolving role of interventionalists in long-term medical management and team-based care.
LP(a) in 2026
Deepak L. Bhatt, M.D., M.P.H., MSCAI, Mount Sinai Health System, Scarsdale, NY
Lipid Lowering Therapy: How Low Can You Go?
Said Ashraf, MD, FSCAI, AtlantiCare Regional Medical Center, Mainland, Philadelphia, PA
Inflammation: The Role of Colchicine and Novel Agents
Binita Shah, MD, MS, FSCAI, NYU Grossman School of Medicine, New York, NY
SGLT2i and GLP1-RAs: The Sweet Move
Schuyler Schuyler Jones, M.D., Duke University Medical Center, Chapel Hill, NC
See more of: Coronary